In this online, self-learning activity:
Neonatal respiratory distress syndrome (RDS) occurs in 10.1% of preterm infants born at 34 weeks’ gestational age (GA), corresponding to an over 40-fold increased risk as compared to their 39- to 40-week-GA counterparts. The risk decreases with increasing GA; at a GA of 37 weeks, the risk has fallen to just to just three times that of a full-term infants. Aside from premature birth, risk factors include: maternal gestational diabetes, male infant, and multiplets.
The following healthcare professionals: neonatologists; physician assistants, nurse practitioners, nurses, and pharmacists who clinically encounter neonatal patients with RSD.
This program is supported by an educational grant from Mallinckdrodt and Chiesi.
Release Date: March 31, 2018 -- Expiration Date: March 31, 2020
Faculty: Jack Sills, MD
Setting the stage
Treatment options available for RSD
By the end of the session the participant will be able to:
ACCME Activity #201226432
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Dr. Jack H. Sills, MD, Clinical Professor Pediatrics, University of California, Invine, CA has no relevant conflicts of interest to disclose.
Disclosures of Educational Planners: Charles Turck, PharmD has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This program is supported by an educational grant from Mallinkdrodt and Chiesi.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.